We are live on
!
Find out more
BAM
Broadcrest Asset Management Portfolio holdings
AUM
$44.1M
1-Year Est. Return
4.51%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$23.4M
(+26%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
11.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
3
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$11.6M |
| 2 |
Enovis
ENOV
|
+$2.9M |
| 3 |
Tyler Technologies
TYL
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transcat
TRNS
|
+$3.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 51.75% |
| 2 | Healthcare | 32.4% |
| 3 | Consumer Staples | 8.14% |
| 4 | Technology | 7.71% |
Similar funds
MAM
WCPI
NLVP
WAMC
CIEP
IPI
CC
VSAM
Broadcrest Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Broadcrest Asset Management held 7 positions worth $115M, up 26% from $91.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadcrest Asset Management deployed $12.7M of net new capital in Q1 2023, adding to 3 existing holdings.
By sector, the portfolio is most concentrated in Industrials at 52% of assets, down from 57% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Transcat, an estimated $3.4M trimmed.
- Broadcrest Asset Management added most to Bio-Techne in Q1 2023, an estimated $11.6M increase.
- Broadcrest Asset Management's biggest Q1 2023 reduction was Transcat, cutting an estimated $3.4M.
- Broadcrest Asset Management's ten largest holdings make up 100% of its $115M portfolio in Q1 2023.
- Broadcrest Asset Management opened 0 new positions and closed 0 in Q1 2023.
- Broadcrest Asset Management's portfolio value rose 26% quarter-over-quarter to $115M.
Based on Broadcrest Asset Management's 13F filing for Q1 2023, filed 12 May 2023.